Aurora continues to be a trusted partner for healthcare organizations within its target markets with our ability to develop complex and first-few-to-file Small Molecules (including Active Pharmaceutical Ingredients (APIs) and formulations) across multiple therapy areas.

We alongside extended our marketing capabilities with our extensive customer base in both developed and emerging markets by leveraging our unique technological strengths in complex chemistry thereby establishing a strong brand equity for growth.

Our partner network includes Artificial Intelligence enabled RnD that helps in Specification Optimization for various global markets. Critical global products fail to reach ideal growth trajectory as one-product-fits-all approach does not work in a complex global regulatory scenario.